DNA "fingerprints" and segregation analysis of multiple markers in human pedigrees.Alec J. Jeffreys, Bruce A.J. Ponder, Victoria Wilson et al.|PubMed|1986Cited by 284
The carrier state for sickle cell disease is not completely harmlessJulia Xu, Swee Lay Thein|Haematologica|2019Cited by 82
A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell diseaseJulia Xu, Swee Lay Thein, Timothy Lequang et al.|Blood|2022Cited by 72
Revisiting anemia in sickle cell disease and finding the balance with therapeutic approachesJulia Xu, Swee Lay Thein|Blood|2022Cited by 32
Mitapivat (AG-348) Demonstrates Safety, Tolerability, and Improvements in Anemia, Hemolysis, Oxygen Affinity, and Hemoglobin S Polymerization Kinetics in Adults with Sickle Cell Disease: A Phase 1 Dose Escalation StudyJulia Xu, Swee Lay Thein, Anna Conrey et al.|Blood|2021Cited by 9